PPTA

ANALYST NOTE: PERPETUA RESOURCES CORP. (PPTA) DATE: 2026-06-13 CURRENT PRICE: $24.32

1. Structural Readiness

• Conservative Entry: Not yet defined (requires breakout confirmation).
• Aggressive/Pre-Breakout Entry: $24.32 (Current Price).
• Breakout Level: Not yet established (requires price to close above the upper bound of the current consolidation range).
• Extension: Not applicable (price is within the consolidation range, not extended above the breakout).
• ATR Context: Current ATR is 7.6% (Very High). This indicates elevated volatility, which increases the risk of whipsaws during the forming phase but suggests significant potential for a large move once the breakout occurs.
• Pivot Strength: Not yet determined (requires breakout confirmation).

2. Thesis Layer

• Primary Secular Theme: Critical Minerals & Materials → Specialty & Advanced Materials.
• Directness: Tier Direct.
• Conviction Weighting: The company is a primary beneficiary of the U.S. strategic imperative to secure domestic supply chains for antimony and gold. The thesis is reinforced by the "Growth Leader" archetype, suggesting the market is pricing in a transition from a development-stage entity to a production-stage operator. The exposure is singular but highly concentrated in a sector with significant government tailwinds (DOE/USFS/USACE involvement).

3. Business Overview

Perpetua Resources Corp. is developing the Stibnite Gold Project in Idaho, USA. The project is a brownfield redevelopment intended to produce gold, silver, and, most critically, antimony.

• Business Model: The company operates as a project developer transitioning to a producer. The model relies on securing project financing to fund construction, followed by the sale of critical minerals (antimony) and precious metals (gold/silver).
• Key Evidence (as of 2026-06-13):
• Financing Status: As of May 11, 2026, the U.S. EXIM board had initiated the final step (notification to Congress) for a $2.7 billion senior secured loan. The board was expected to make a final decision in Q2 2026 (E1, E2).
• Capital Sufficiency: Management stated that if the loan is approved, combined with $669.5 million in cash on hand (as of March 31, 2026), the company would have sufficient capital to finance $2,576 million in direct construction costs (E3).
• Regulatory Milestones:
• USFS issued Record of Decision (ROD) for the 2021 Modified Mine Plan on Jan 3, 2025 (E6).
• USACE issued ROD for CWA Section 404 permit on May 19, 2025 (E7).
• USFS approved the Plan of Operations in October 2025 (E8).
• Early works construction began on October 21, 2025 (E9).
• Strategic Partnerships: A partnership with Idaho National Labs was announced for pilot-scale testing of antimony trisulfide (E12).
• Management Expectations: As of March 31, 2026, management stated the focus was on advancing the project toward a full construction decision in 2026 (E10).

4. Archetype and Conviction

• Archetype: Growth Leader.
• *Fit:* The company is transitioning from a capital-intensive development phase to a production phase, driven by a unique asset (only U.S. antimony reserves) and massive government-backed financing. The "Growth Leader" label reflects the potential for significant revenue inflection upon the start of construction and eventual production.
• Valuation & Conviction Stack:
• Thesis Strength: High. The U.S. government's push for domestic critical minerals is a structural, non-cyclical driver.
• Evidence Quality: High. The evidence block contains specific, dated regulatory approvals and financing milestones from 2025-2026.
• Structural Quality: The project has cleared major regulatory hurdles (USFS, USACE) and is in the "early works" phase. The financing structure ($2.7B loan + $669.5M cash) covers the estimated capex ($2.576B), suggesting a funded path to construction.
• Rerating Potential: Significant. If the EXIM loan is finalized and the construction decision is made in 2026, the company moves from a "development story" to a "construction execution story," which typically commands a higher multiple.

5. Invalidations, Strengtheners, and Gaps

• Invalidation Triggers:
• Failure of the U.S. EXIM board to approve the $2.7 billion loan in Q2 2026.
• Delays in the "full construction decision" beyond the 2026 management expectation.
• Strengtheners:
• Final approval of the EXIM loan.
• Announcement of the "Full Construction Decision" (FCD) in 2026.
• Successful completion of pilot-scale testing with Idaho National Labs.
• Evidence Gaps:
• Missing: Specific details on the *terms* of the EXIM loan (interest rate, covenants) beyond the approval status.
• Missing: Detailed breakdown of the $2,576 million capex estimate (e.g., contingency percentages, inflation adjustments).
• Missing: Current production cost estimates (AISC) for the Stibnite project, as the mine is not yet in production.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: U.S. EXIM board initiated final loan approval steps for $2.7B; USFS and USACE issued critical permits in 2025; Early works construction began Oct 2025; Management targets full construction decision in 2026. Key risks: EXIM loan approval could be delayed or denied; Very high ATR (7.6%) indicates elevated volatility and potential for sharp downside if sentiment shifts; Construction execution risk on a brownfield site; Regulatory delays could push FCD beyond 2026. Sizing hint: Position size should be reduced relative to a confirmed breakout due to the "Forming" state and high volatility; treat as a binary event play on the EXIM vote. Expected path: Management expects to secure financing and make a construction decision in 2026; if approved, the company will transition to full-scale construction, potentially driving a breakout from the current consolidation range. Expected horizon: 6 to 12 months (aligned with the 2026 construction decision timeline).